SLE: Clinical Trials

4 trials for SLE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Recruiting 4
Phase 22Recruiting 2

Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
CART19 - SLE, Systemic Lupus Erythematosus (SLE)
Phase 1 / Phase 2RecruitingChildren's Hospital of Philadelphia242025-05-062026-09-24
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
CLN-978 - SLE, SLE (Systemic Lupus)
Phase 1RecruitingCullinan Therapeutics Inc.242025-01-212026-10-26
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
Physical examination, Electrocardiogram, SF-36 questionnaire - SLE, Lupus
Phase 1RecruitingLiveKidney.Bio102025-01-072025-09-11
A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
APG-2575, Placebo - SLE
Phase 1 / Phase 2RecruitingAscentage Pharma Group Inc.402024-08-092025-12-16

Narrower conditions

Lupus Erythematosus, Systemic (3)  ·  Lupus Nephritis (1)

Broader conditions

Autoimmune Diseases (3)  ·  Connective Tissue Diseases (3)  ·  Immune System Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

CTL019 chimeric antigen receptor (1)  ·  Electrocardiography (1)  ·  Lisaftoclax (1)  ·  Physical Examination (1)  ·  Pregnancy Tests (1)  ·  Urinalysis (1)

Sponsors

Ascentage Pharma Group Inc. (1)  ·  Children's Hospital of Philadelphia (1)  ·  Cullinan Therapeutics Inc. (1)  ·  LiveKidney.Bio (1)

Countries

United States (3)  ·  Australia (1)  ·  Bulgaria (1)  ·  China (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Moldova (1)  ·  Romania (1)  ·  Spain (1)

Top investigators

Caitlin Elgarten, MD (1)  ·  Sheng Chen, Ph.D (1)